Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1961 Sep;40(9):1656–1662. doi: 10.1172/JCI104388

AN IMMUNOLOGIC BASIS FOR ACQUIRED RESISTANCE TO ORAL ADMINISTRATION OF HOG INTRINSIC FACTOR AND VITAMIN B12 IN PERNICIOUS ANEMIA*

Louis Lowenstein 1, Bernard A Cooper 1, Lauder Brunton 1, Susan Gartha 1
PMCID: PMC290859  PMID: 13763834

Full text

PDF
1661

Images in this article

1659Image
on p.1659

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CONNOLLY J. H., DICK G. W. Antibody response following intradermal or oral administration of formalinised poliomyelitis. Lancet. 1958 Aug 16;2(7042):333–336. doi: 10.1016/s0140-6736(58)90256-3. [DOI] [PubMed] [Google Scholar]
  2. GLASS G. B. J., STEPHANSON L., RICH M., LAUGHTON R. W. Intrinsic-factor activity of human gastric juice after fractionation by continuous electrophoresis on paper curtain. Br J Haematol. 1957 Oct;3(4):401–411. doi: 10.1111/j.1365-2141.1957.tb05539.x. [DOI] [PubMed] [Google Scholar]
  3. GRASSMANN W., HANNIG K. Ein quantitatives Verfahren zur Analyse der Serumproteine durch Papierelektrophorese. Hoppe Seylers Z Physiol Chem. 1952;290(1-2):1–27. [PubMed] [Google Scholar]
  4. GYENES L., ROSE B., SEHON A. H. Isolation of antibodies on antigen-polystyrene conjugates. Nature. 1958 May 24;181(4621):1465–1466. doi: 10.1038/1811465a0. [DOI] [PubMed] [Google Scholar]
  5. LOWENSTEIN L., BRUNTON L., SHAPIRO L., DE LEEUW N., DUFRESNE M. Maintenance therapy of pernicious anaemia with oral administration of intrinsic factor and vitamin B12. Can Med Assoc J. 1957 Nov 15;77(10):923–930. [PMC free article] [PubMed] [Google Scholar]
  6. McGARRY E., SEHON A. H., ROSE B. The isolation and electrophoretic characterization of the proteins in the urine of normal subjects. J Clin Invest. 1955 Jun;34(6):832–844. doi: 10.1172/JCI103138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. SCHWARTZ M. Intrinsic factor antibody in serum from patients with pernicious anaemia. Lancet. 1960 Dec 10;2(7163):1263–1267. doi: 10.1016/s0140-6736(60)92461-2. [DOI] [PubMed] [Google Scholar]
  8. SCHWARTZ M., LOUS P., MEULENGRACHT E. Absorption of vitamin B12 in pernicious anaemia; defective absorption induced by prolonged oral treatment. Lancet. 1958 Dec 6;2(7058):1200–1204. doi: 10.1016/s0140-6736(58)92355-9. [DOI] [PubMed] [Google Scholar]
  9. SCHWARTZ M., LOUS P., MEULENGRACHT E. Reduced effect of heterologous intrinsic factor after prolonged oral treatment in pernicious anaemia. Lancet. 1957 Apr 13;272(6972):751–753. doi: 10.1016/s0140-6736(57)91022-x. [DOI] [PubMed] [Google Scholar]
  10. STAVITSKY A. B., ARQUILLA E. R. Studies of proteins and antibodies by specific hemagglutination and hemolysis of proteinconjugated erythrocytes. Int Arch Allergy Appl Immunol. 1958;13(1-2):1–38. doi: 10.1159/000228473. [DOI] [PubMed] [Google Scholar]
  11. TAYLOR K. B. Inhibition of intrinsic factor by pernicious anaemia sera. Lancet. 1959 Aug 15;2(7094):106–108. doi: 10.1016/s0140-6736(59)92216-0. [DOI] [PubMed] [Google Scholar]
  12. TAYLOR K. B., MORTON J. A. An antibody to Castle's intrinsic factor. Lancet. 1958 Jan 4;1(7010):29–30. doi: 10.1016/s0140-6736(58)92520-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES